Experimental and numerical investigations of the optical and thermal aspects of a PCM-glazed unit

This paper reports on the thermal and optical characterisation of PCM (phase change material) RT27 using the T-history method and spectrophotometry principles, respectively, and the experimental and numerical performance evaluation of a PCM-glazed unit. Various relationships describing the variations in the extinction, scattering and absorption coefficients within the phase change region were developed, and were validated in a numerical CFD model. The results show that: (i) during rapid phase changes, the transmittance spectra from the PCM are unstable, while under stable conditions visible transmittance values of 90% and 40% are obtained for the liquid and phases, respectively; (ii) the radiation scattering effects are dominant in the solid phase of the PCM, while radiation absorption dominates in the liquid phase; (iii) the optical/radiation performance of PCM can be successfully modelled using the liquid fraction term as the main variable; (iv) the addition of PCM improves the thermal mass of the unit during phase change, but risks of overheating may be a significant factor after the PCM has melted; (v) although the day-lighting aspects of PCM-glazed units are favourable, the change in appearance as the PCM changes phase may be a limiting factor in PCM-glazed units

Unconventional particle-hole mixing in the systems with strong superconducting fluctuations

Development of the STM and ARPES spectroscopies enabled to reach the resolution level sufficient for detecting the particle-hole entanglement in superconducting materials. On a quantitative level one can characterize such entanglement in terms of the, so called, Bogoliubov angle which determines to what extent the particles and holes constitute the spatially or momentum resolved excitation spectra. In classical superconductors, where the phase transition is related to formation of the Cooper pairs almost simultaneously accompanied by onset of their long-range phase coherence, the Bogoliubov angle is slanted all the way up to the critical temperature Tc. In the high temperature superconductors and in superfluid ultracold fermion atoms near the Feshbach resonance the situation is different because of the preformed pairs which exist above Tc albeit loosing coherence due to the strong quantum fluctuations. We discuss a generic temperature dependence of the Bogoliubov angle in such pseudogap state indicating a novel, non-BCS behavior. For quantitative analysis we use a two-component model describing the pairs coexisting with single fermions and study their mutual feedback effects by the selfconsistent procedure originating from the renormalization group approach.Comment: 4 pages, 4 figure

A Conformally Invariant Holographic Two-Point Function on the Berger Sphere

We apply our previous work on Green's functions for the four-dimensional quaternionic Taub-NUT manifold to obtain a scalar two-point function on the homogeneously squashed three-sphere (otherwise known as the Berger sphere), which lies at its conformal infinity. Using basic notions from conformal geometry and the theory of boundary value problems, in particular the Dirichlet-to-Robin operator, we establish that our two-point correlation function is conformally invariant and corresponds to a boundary operator of conformal dimension one. It is plausible that the methods we use could have more general applications in an AdS/CFT context.Comment: 1+49 pages, no figures. v2: Several typos correcte

Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached$8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total,$40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this,$13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and$1.4 billion was repurposed from existing health projects. $3.1 billion (22.4$2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7$1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe